A 10-person team of researchers at the Salk Institute for Biological Studies has been awarded an eight-year, $19.2 million grant to investigate mechanisms underlying Alzheimer’s disease and aging-related cognitive decline and uncover new therapies.
The grant, announced Friday by the research... Read more »
One of the biggest gambles in biotech history is about to be tested on Wall Street.
Moderna, the high-flying yet secretive developer of messenger RNA therapeutics, filed papers on Friday afternoon outlining its long-awaited IPO. In its prospectus, Moderna set an... Read more »
Acquisitions, partnerships, and an FDA approval mark this week’s roundup in Boston technology news. Read on for more:
—Boston University is adding artificial intelligence education to its electrical and computer engineering courses through a partnership with Boston A.I. company Neurala, to... Read more »
The humble cell has been getting a lot of attention in the medical world lately, and Ann Arbor, MI-based biotech startup Celsee wants to make it easier to study them.
As precision medicine and genomic analysis become more sophisticated, clinicians are... Read more »
There was plenty at stake in this week’s midterm elections, and not just in terms of political wins and losses. With congress now divided—Democrats took back control of the House and Republicans extended their majority in the Senate—the implications are significant... Read more »
It’s been a busy week for Wisconsin’s innovation community, with entrepreneurship events taking place statewide for Startup Wisconsin Week (check out highlights on Twitter). Here are some of the other headlines from the past week:
—Wauwatosa-based Froedtert Health, which runs... Read more »
Each new technology has a story behind it. On Dec. 5, our Xchange Forum will offer a behind-the-scenes look at how some of them aim to transform healthcare.
Xconomy’s San Francisco Biotech: The Next Generation, will feature three Bay Area... Read more »
Former Google CEO Eric Schmidt says the next five years of artificial intelligence and machine learning will be more like Apple’s Siri and Amazon’s Alexa than a self-driving sedan or a robo-surgeon taking out your appendix.
“There are still significant errors,... Read more »
All-seeing orbs, a distant planet and source of a life-giving drug, interstellar faster-than-light space travel, a carbon-freezing technique used to lock away enemies.
The science fiction and fantasy creations—carbonite, palantir, Arrakis, warp drive—evoke the sort of futuristic vision that many startups... Read more »